4.6 Review

Heterogeneous Myeloid Cells in Tumors

期刊

CANCERS
卷 13, 期 15, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13153772

关键词

monocytes; tumor-associated macrophages; dendritic cells; cancer-related circulating neutrophils; tumor-associated neutrophils; myeloid-derived suppressor cells; tumors; tumor microenvironment; angiogenesis; immunomodulation; chemotherapy; immunotherapy

类别

资金

  1. NIH [R01CA218076]
  2. NIH COBRE [1P20GM109091-01]
  3. St. Baldrick's Foundation
  4. Aplastic Anemia & MDS International Foundation
  5. NSF [1736150]
  6. USC SOM IRF Endowment Fund

向作者/读者索取更多资源

Myeloid cells play a crucial role in tumor development, with pro-tumor and anti-tumor functions that impact tumor cells, tumor microenvironment, and immune system.
Simple Summary It is well known that lymphocytes play a key role in the immunosurveillance for tumors. Accumulating evidence indicates that myeloid cells also have a large impact on tumor development. The tumor-associated myeloid cells (TAMCs) are heterogeneous and exert distinct and even opposing effects on tumor cells and tumor microenvironment (TME). In addition, myeloid cells play a critical role in modulating the behavior of lymphocytes, resulting in immunostimulatory or immunosuppressive TME cues that stimulate or suppress tumor development. Based on the function of myeloid cells in tumors, there are pro-tumor and anti-tumor myeloid cells. They are involved in pleiotropic processes, including growth, survival, differentiation, stemness, invasiveness, dissemination and metastasis of tumor cells, angiogenesis, remodeling of TME, immunomodulation, and response to cancer therapy. Understanding the function and mechanism of TAMCs in tumors will shed light on uncovering novel therapy. Accumulating studies highlight a critical role of myeloid cells in cancer biology and therapy. The myeloid cells constitute the major components of tumor microenvironment (TME). The most studied tumor-associated myeloid cells (TAMCs) include monocytes, tumor-associated macrophages (TAMs), dendritic cells (DCs), cancer-related circulating neutrophils, tumor-associated neutrophils (TANs), and myeloid-derived suppressor cells (MDSCs). These heterogenous myeloid cells perform pro-tumor or anti-tumor function, exerting complex and even opposing effects on all stages of tumor development, such as malignant clonal evolution, growth, survival, invasiveness, dissemination and metastasis of tumor cells. TAMCs also reshape TME and tumor vasculature to favor tumor development. The main function of these myeloid cells is to modulate the behavior of lymphocytes, forming immunostimulatory or immunosuppressive TME cues. In addition, TAMCs play a critical role in modulating the response to cancer therapy. Targeting TAMCs is vigorously tested as monotherapy or in combination with chemotherapy or immunotherapy. This review briefly introduces the TAMC subpopulations and their function in tumor cells, TME, angiogenesis, immunomodulation, and cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据